OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation.
Identification of tumor suppressor genes (TSGs) silenced by CpG methylation uncovers the molecular mechanism of tumorigenesis and potential tumor biomarkers. Loss of heterozygosity at 11q25 is common in multiple tumors including nasopharyngeal carcinoma (NPC). OPCML, located at 11q25, is one of the...
Main Authors: | Yan Cui, Ying Ying, Andrew van Hasselt, Ka Man Ng, Jun Yu, Qian Zhang, Jie Jin, Dingxie Liu, Johng S Rhim, Sun Young Rha, Myriam Loyo, Anthony T C Chan, Gopesh Srivastava, George S W Tsao, Grant C Sellar, Joseph J Y Sung, David Sidransky, Qian Tao |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-08-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2500176?pdf=render |
Similar Items
-
Correction: OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation
Published: (2008-01-01) -
OPCML is hypermethylated in a subset of patients with metaplastic changes in their esophagus
by: Natalia Castaño-Rodríguez, et al.
Published: (2018-12-01) -
OPCML Methylation and the Risk of Ovarian Cancer: A Meta and Bioinformatics Analysis
by: Yang Shao, et al.
Published: (2021-03-01) -
OPCML, a novel systems regulator of tyrosine kinase signaling in ovarian and other cancers
by: Gabra H
Published: (2012-04-01) -
TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma
by: Ma Ning, et al.
Published: (2010-11-01)